Investments

Driving continued enterprise value creation

Portfolio
Apara Autism Centers
Houston, TX
active
Investment: 2019

Apara provides Applied Behavior Analysis (ABA) therapy to children with autism. Apara delivers integrative and collaborative programs designed to give the child the best therapy and support options available while also supporting the caregivers and family members.

Visit Website
Avid Health at Home
Chicago, IL
active
Investment: 2023

Avid Health at Home (“Avid”) is a post-acute care platform focused on partnering with successful non-medical homecare businesses in select markets to provide access to high-quality care for individuals of all ages.

Visit Website
Deep Eddy Therapy
Austin, TX
active
Investment: 2022

Deep Eddy Psychotherapy (“Deep Eddy”) is a behavioral health platform that delivers high-quality patient care for children and adults in individual, couples, family and group settings.

Visit Website
Effective School Solutions
Summit, NJ
active
Investment: 2018

Effective School Solutions (ESS) partners with school districts to provide in-district mental health solutions to help students with emotional and behavioral challenges get the support they need to realize their full potential.

Visit Website
Focus Staff
Dallas, TX
active
Investment: 2023

Focus Staff Services, LLC (“Focus”) is a leading provider of workforce solutions focused on temporary nurse and allied staffing services to healthcare facilities across the United States, including many leading integrated delivery networks (IDNs) and acute care hospitals.

Visit Website
Paradigm Health
Indianapolis, IN
active
Investment: 2021

Paradigm Health is a provider of high-quality, compassionate and patient-focused hospice and palliative care. Paradigm aims to embrace each patient along with family members in order to maintain and maximize quality of life in a personal setting.

Visit Website
Tekton Research
Austin, TX
active
Investment: 2023

Tekton Research (“Tekton”) is a leading clinical trial site network partnering with global pharmaceutical companies and CROs.

Visit Website
The Oncology Institute of Hope and Innovation (TOI)
Los Angeles, CA
active
Investment: 2018

The Oncology Institute of Hope and Innovation (TOI) provides extensive, high-quality, patient-centric oncology care and is dedicated to excelling in cancer awareness, prevention, diagnosis, treatment and education.

Visit Website
ThermoTek
Dallas, TX
active
Investment: 2020

ThermoTek provides a broad range of temperature management solutions to the medical and industrial end markets, specifically cold compression devices used in post-orthopedic surgery rehabilitation and cooling units used in industrial applications.

Visit Website
AlgoRx Pharmaceuticals
San Francisco, CA
Prior firm investment
exited
Investment: 2002
Realization: 2005

AlgoRx is a clinical-stage biopharmaceutical company focused on developing and commercializing topical products with pain management applications.

Visit Website
Avadyne Health
Moline, IL
Prior firm investment
exited
Investment: 2006
Realization: 2016

Avadyne Health is a provider of revenue cycle management (RCM) services to a wide range of healthcare providers across the nation.

Visit Website
Community Education Centers (CEC)
West Caldwell, NJ
Prior firm investment
exited
Investment: 2010
Realization: 2017

Community Education Centers (CEC) is a leading national provider of rehabilitative services for offenders through re-entry and in-custody treatment programs as well as comprehensive management services for county, state, and federal correctional and detention facilities.

Visit Website
Essence Healthcare
St. Louis, MO
Prior firm investment
exited
Investment: 2011
Realization: 2017

Essence Healthcare, a leading Medicare Advantage health plan and subsidiary of Essence Group Holdings Corporation (along with Lumeris), has been consistently rated one of the highest quality plans in the nation with an overall plan rating of 4.5 Stars or higher since 2015. Recognized by U.S. News & World Report’s 2017 Best Medicare Plans as one of the highest-rated plans in Missouri and Illinois, Essence Healthcare and its consistently high ratings reflect the company’s daily commitment to delivering the best possible healthcare experience to our valued members.

Visit Website
Essia Health
Los Angeles, CA
Prior firm investment
exited
Investment: 2015
Realization: 2018

Essia Health ensures clinical teams harness the full power of EMR technologies by enabling them to deliver the highest quality care and documentation while achieving appropriate reimbursement and operational efficiency.

Visit Website
IPG
Atlanta, GA
Prior firm investment
exited
Investment: 2014
Realization: 2021

IPG, the leading provider of surgical cost management solutions, is delivering on its mission of improving the quality and affordability of surgical care. By partnering with the leading national and regional health plans (representing over 100 million lives), contracted device manufacturers (covering virtually all medical devices), surgery centers, hospitals and health systems, IPG provides surgical cost transparency, robust analytics and the site-of-care expertise needed to better navigate and manage the $150 billion medical device marketspace.

Visit Website
LipoScience
Raleigh, NC
Prior firm investment
exited
Investment: 2006
Realization: 2014

LipoScience, a medical product company focused on nuclear magnetic resonance (NMR) technology, developed diagnostic tests that improved the quality of patient care for cardiovascular, metabolic and other diseases.

Visit Website
Lumeris
St. Louis, MO
Prior firm investment
exited
Investment: 2011
Realization: 2017

Lumeris, a value-based care (VBC) managed services operator for health systems and providers, is a subsidiary of Essence Group Holdings Corporation (along with Essence Healthcare). Lumeris aligns providers and payers across populations with technologies, processes, behaviors and information to achieve high-quality, cost-effective care with satisfied consumers — and engaged physicians.

Visit Website
MacroGenics
Rockville, MD
Prior firm investment
exited
Investment: 2002
Realization: 2013

MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains.

Visit Website
Medivance
Boulder, CO
Prior firm investment
exited
Investment: 2001
Realization: 2011

Medivance, a medical product company focused on the treatment of therapeutic hypothermia, developed the Arctic Sun™, a machine that helps doctors precisely control body temperature.

Visit Website
MedServe
Houston, TX
Prior firm investment
exited
Investment: 2004
Realization: 2008

MedServe provides medical waste removal and destruction and related environmental services to hospitals, health care clinics, doctors’ offices and other generators of medical waste.

Visit Website
Metabolon
Raleigh, NC
Prior firm investment
active
Investment: 2013

Metabolon is the global leader in metabolomics, a powerful phenotyping technology for advancing biomarker discovery, diagnostic testing & precision medicine. The Company’s Precision Metabolomics™ is a powerful AI-based technology for assessing health and delivering biomarker discoveries, innovative diagnostic tests, and valuable data for genomics and population health studies. Precision Metabolomics™ also accelerates R&D across the pharmaceutical, biotechnology, microbiome, consumer products and nutrition industries.

Visit Website
Paragon Bioservices
Baltimore, MD
Prior firm investment
exited
Investment: 2014
Realization: 2019

Paragon Bioservices is a contract development and manufacturing organization (CDMO) focused on gene therapies delivered via adeno-associated virus (AAV) vectors, as well as next generation vaccines, oncology immunotherapies and other complex biologics.

Visit Website
Pet DRx
Los Angeles, CA
Prior firm investment
exited
Investment: 2006
Realization: 2010

Pet DRx is transforming the practice of veterinary care in America by creating a network of 24-hour, state-of-the-art veterinary hospitals.

Visit Website
The companies described in the "Investments at Prior Firms" section are companies that one or more of the management of Havencrest worked with prior to Havencrest. These companies are displayed for illustrative purposes to describe the background of Havencrest’s management. Havencrest is not making a statement on the performance of these investments and is not claiming the performance track record of these investments.